rs1406
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001238.4(CCNE1):c.*428C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 249,640 control chromosomes in the GnomAD database, including 9,380 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.28 ( 6188 hom., cov: 32)
Exomes 𝑓: 0.25 ( 3192 hom. )
Consequence
CCNE1
NM_001238.4 3_prime_UTR
NM_001238.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0800
Publications
23 publications found
Genes affected
CCNE1 (HGNC:1589): (cyclin E1) The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK2, whose activity is required for cell cycle G1/S transition. This protein accumulates at the G1-S phase boundary and is degraded as cells progress through S phase. Overexpression of this gene has been observed in many tumors, which results in chromosome instability, and thus may contribute to tumorigenesis. This protein was found to associate with, and be involved in, the phosphorylation of NPAT protein (nuclear protein mapped to the ATM locus), which participates in cell-cycle regulated histone gene expression and plays a critical role in promoting cell-cycle progression in the absence of pRB. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.4 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.278 AC: 42209AN: 151890Hom.: 6172 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
42209
AN:
151890
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.246 AC: 23971AN: 97632Hom.: 3192 Cov.: 0 AF XY: 0.243 AC XY: 11214AN XY: 46084 show subpopulations
GnomAD4 exome
AF:
AC:
23971
AN:
97632
Hom.:
Cov.:
0
AF XY:
AC XY:
11214
AN XY:
46084
show subpopulations
African (AFR)
AF:
AC:
1409
AN:
4360
American (AMR)
AF:
AC:
1083
AN:
3136
Ashkenazi Jewish (ASJ)
AF:
AC:
896
AN:
5512
East Asian (EAS)
AF:
AC:
4819
AN:
12224
South Asian (SAS)
AF:
AC:
423
AN:
996
European-Finnish (FIN)
AF:
AC:
490
AN:
1990
Middle Eastern (MID)
AF:
AC:
80
AN:
564
European-Non Finnish (NFE)
AF:
AC:
12924
AN:
61152
Other (OTH)
AF:
AC:
1847
AN:
7698
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
861
1722
2582
3443
4304
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.278 AC: 42243AN: 152008Hom.: 6188 Cov.: 32 AF XY: 0.284 AC XY: 21095AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
42243
AN:
152008
Hom.:
Cov.:
32
AF XY:
AC XY:
21095
AN XY:
74288
show subpopulations
African (AFR)
AF:
AC:
13684
AN:
41430
American (AMR)
AF:
AC:
5285
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
571
AN:
3472
East Asian (EAS)
AF:
AC:
1929
AN:
5164
South Asian (SAS)
AF:
AC:
2000
AN:
4822
European-Finnish (FIN)
AF:
AC:
2655
AN:
10566
Middle Eastern (MID)
AF:
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15212
AN:
67958
Other (OTH)
AF:
AC:
539
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1500
3000
4501
6001
7501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1557
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.